Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease.
Kazuki OhashiToru IshikawaAsami HoshiiTamaki HokariHirohito NoguchiMitsuyuki SuzukiHiroshi HirosawaMichitaka ImaiYuta MitobeToshiaki YoshidaPublished in: Journal of clinical medicine (2021)
Although dual-energy X-ray absorptiometry (DXA) and body impedance analysis are commonly used to measure skeletal muscle mass (SMM), a computed tomography (CT) scan is preferred in clinical practice. We aimed to propose the cut-off values of skeletal muscle mass index (SMI) calculated using CT scans, using DXA as the reference method. We retrospectively assessed 589 patients with chronic liver disease. The SMI was assessed using appendicular SMM by DXA and total muscle area at the level of the third lumbar vertebra (L3) calculated by CT. The cut-off value was determined with reference to the Asian Working Group for Sarcopenia criteria. DXA identified 251 (42.6%) patients as having presarcopenia. In men, the cut-off value of SMI for presarcopenia was determined to be 45.471 cm2/m2, with an area under the curve (AUC) of 0.863 (95% confidence interval (CI): 0.823 to 0.903), and in women, this value was determined to be 35.170 cm2/m2, with an AUC of 0.846 (95% CI: 0.800 to 0.892). Cohen's kappa coefficient was 0.575 (95% CI: 0.485-0.665) in men and 0.539 (95% CI: 0.438-0.639) in women.
Keyphrases
- dual energy
- computed tomography
- skeletal muscle
- image quality
- positron emission tomography
- polycystic ovary syndrome
- end stage renal disease
- clinical practice
- contrast enhanced
- newly diagnosed
- insulin resistance
- magnetic resonance imaging
- ejection fraction
- chronic kidney disease
- middle aged
- peritoneal dialysis
- prognostic factors
- pregnancy outcomes
- diffusion weighted imaging
- cervical cancer screening
- pregnant women
- nuclear factor
- metabolic syndrome
- adipose tissue
- toll like receptor
- type diabetes
- inflammatory response
- mass spectrometry
- patient reported
- patient reported outcomes